INCYTE CORP INCY revenue by segment, product and geography
In its fiscal year ending 2025-12-31, INCYTE CORP reported revenue across 1 business segments; the largest, Reportable Segment, was $5.14B, 100.0% of the filed sum (+21.2% against the prior period in the same filing).
Reported segment mix
figures as filed · share of the filed sum · change vs the prior period in the same filing- Reportable Segment$5.14B100.0%+21.2% yoy
Members sum to the consolidated $5.14B for this period.
- Product$4.35Bshare n/a+20.3% yoy
- JAKAFI$3.09Bshare n/a+10.8% yoy
- OPZELURA$678Mshare n/a+33.5% yoy
- Royalty$637Mshare n/a+9.9% yoy
- JAKAVI Royalty Revenues$458Mshare n/a+9.3% yoy
- NIKTIMVO$152Mshare n/ano prior
- Milestone And Contract Revenues$150Mshare n/a+248.8% yoy
- Olumiant Royalty$145Mshare n/a+6.7% yoy
- +6 more members in the filing
member sum exceeds the consolidated figure: this axis carries more than one breakdown, so shares are not computed.
- United States$4.8B93.4%+20.8% yoy
- Europe$324M6.3%+24.3% yoy
- Other countries$17.6M0.3%+182.7% yoy
Members sum to the consolidated $5.14B for this period.
- Reportable Segment$1.67B100.0%no prior
Change is against the same quarter a year earlier, as reported in the same 10-Q.
Source: SEC DERA Financial Statement and Notes data sets. Dimensional XBRL facts on the business-segment, product/service and geographic axes; the engine keeps the accession of every figure. Descriptive and educational, not advice.
About these figures
Companies tag segment, product and geographic revenue as dimensional XBRL facts in their 10-K and 10-Q filings. The SEC publishes those facts in its DERA Financial Statement and Notes data sets; TrendNalysis ingests each monthly file and serves the facts exactly as filed, keyed to the accession of the filing. Shares are of the filed sum. Where a filer tags more than one breakdown on one axis, the sum exceeds consolidated revenue and no shares are computed; where the members do not add up to the consolidated figure, the residual is stated rather than hidden. Missing is never zero.
Descriptive and educational; not investment advice. Methodology and data lineage.